• Home
  • Our Research
  • Upcoming Webinars
  • Potential Investors
  • About
  • More
    • Home
    • Our Research
    • Upcoming Webinars
    • Potential Investors
    • About
  • Home
  • Our Research
  • Upcoming Webinars
  • Potential Investors
  • About

About Gut-Brain Axis Therapeutics

Our Vision

We are dedicated to innovative research to develop new products to improve the gut microbiota and gut health, and thereby improve brain health and overall functioning.


Our initial focus is on developing Microbiota Transplant Therapy for Autism and Pitt Hopkins Syndrome.

About Us

James B. Adams, PhD

Rosa Krajmalnik-Brown, PhD

Rosa Krajmalnik-Brown, PhD

President/CEO

Rosa Krajmalnik-Brown, PhD

Rosa Krajmalnik-Brown, PhD

Rosa Krajmalnik-Brown, PhD

Chief Science Officer

Alexander Khoruts, MD

Rosa Krajmalnik-Brown, PhD

Alexander Khoruts, MD

Chief Medical Officer

Michael Sadowsky, PhD

Khemlal Nirmalkar, PhD

Alexander Khoruts, MD

Chief Manufacturing and Operations Officer

Khemlal Nirmalkar, PhD

Khemlal Nirmalkar, PhD

Khemlal Nirmalkar, PhD

Chief Research Scientist

Frequently Asked Questions

Two of the primary publications are available for free at:

 

  • Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study - PubMed (nih.gov)
  • Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota - PubMed (nih.gov)


More information is available at http://autism.asu.edu


Our next clinical trials will be at Arizona State University and other locations.  You can sign up to be contacted about future studies at http://autism.asu.edu.


  • Potential Investors

Gut-Brain Axis Therapeutics

Copyright © 2024 Gut-Brain Axis Therapeutics - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept